Page 162 - 南京医科大学自然版

第46卷第6期
·944 · 南 京 医 科 大 学 学 报 2026年6月

breast cancer［J］. J Biol Chem，2020，295（41）：14140- obic glycolysis and overcomes chemoresistance by induc⁃
14152 ing Cdh1 ⁃ mediated Skp2 ubiquitination［J］. Am J Chin
［52］DAS C K，PAREKH A，PARIDA P K，et al. Lactate dehy⁃ Med，2023，51（3）：723-740
drogenase a regulates autophagy and tamoxifen resistance ［61］DONG X，LI K，WANG R，et al. Targeting Skp2 by tanshi⁃
in breast cancer［J］. Biochim Biophys Acta Mol Cell Res， none IIA overcomes chemoresistance in colorectal can⁃
2019，1866（6）：1004-1018 cer［J］. Cell Biol Toxicol，2025，41（1）：135
［53］CHEN X，LUO R，ZHANG Y，et al. Long noncoding RNA ［62］SHEN D，DENG Z，LIU W，et al. Melatonin inhibits blad⁃
DIO3OS induces glycolytic ⁃ dominant metabolic repro⁃ der tumorigenesis by suppressing PPARγ/ENO1⁃mediat⁃
gramming to promote aromatase inhibitor resistance in ed glycolysis［J］. Cell Death Dis，2023，14（4）：246
breast cancer［J］. Nat Commun，2022，13（1）：7160 ［63］HU Y，LOU X，ZHANG K，et al. Tumor necrosis factor re⁃
［54］CHEN Y，ZHANG J，ZHANG M，et al. Baicalein resensi⁃ ceptor 2 promotes endothelial cell⁃mediated suppression
+
tizes tamoxifen⁃resistant breast cancer cells by reducing of CD8 T cells through tuning glycolysis in chemoresis⁃
aerobic glycolysis and reversing mitochondrial dysfunc⁃ tance of breast cancer［J］. J Transl Med，2024，22（1）：
tion via inhibition of hypoxia⁃inducible factor⁃1α［J］. Clin 672
Transl Med，2021，11（11）：e577 ［64］LI X，ZHANG C，MEI Y，et al. Irinotecan alleviates che⁃
［55］CHEN H，LI Y，LI H，et al. NBS1 lactylation is required moresistance to anthracyclines through the inhibition of
for efficient DNA repair and chemotherapy resistance［J］. AARS1⁃mediated BLM lactylation and homologous recom⁃
Nature，2024，631（8021）：663-669 bination repair［J］. Sig Transduct Target Ther，2025，10
［56］FENG J，DAI W，MAO Y，et al. Simvastatin re⁃sensitizes （1）：214
hepatocellular carcinoma cells to sorafenib by inhibiting ［65］XU Q，GAO J，ZHAO R，et al. Akkermansia muciniphila⁃
HIF ⁃ 1α/PPAR ⁃ γ/PKM2 ⁃ mediated glycolysis［J］. J Exp derived pentadecanoic acid enhances oxaliplatin sensitivity
Clin Cancer Res，2020，39（1）：24 in gastric cancer by modulating glycolysis［J］. Pharmacol
［57］BI L，REN Y，FENG M，et al. HDAC11 regulates glycoly⁃ Res，2024，206：107278
sis through the LKB1/AMPK signaling pathway to main⁃ ［66］LU H，TONG W，JIANG M，et al. Mitochondria⁃targeted
tain hepatocellular carcinoma stemness［J］. Cancer Res， multifunctional nanoprodrugs by inhibiting metabolic
2021，81（8）：2015-2028 reprogramming for combating cisplatin ⁃ resistant lung
［58］WANG J，HUANG Q，HU X，et al. Disrupting circadian cancer［J］. ACS Nano，2024，18（32）：21156-21170
rhythm via the PER1⁃HK2 axis reverses trastuzumab re⁃ ［67］ZHANG R，LI R，ZHANG L，et al. A dual ⁃ mechanism
sistance in gastric cancer［J］. Cancer Res，2022，82（8）： based nutrient partitioning nanoregulator for enhanced im⁃
1503-1517 munotherapy against anti⁃PD⁃1 resistant tumors［J］. ACS
［59］YANG J，WANG H，LI B，et al. Inhibition of ACSS2 trig⁃ Nano，2023，17（14）：13461-13473
gers glycolysis inhibition and nuclear translocation to acti⁃ ［68］SCHWENCK J，SONANINI D，COTTON J M，et al. Ad⁃
vate SIRT1/ATG5/ATG2B deacetylation axis，promoting vances in PET imaging of cancer［J］. Nat Rev Cancer，
autophagy and reducing malignancy and chemoresistance 2023，23（7）：474-490
in ovarian cancer［J］. Metabolism，2025，162：156041 （收稿：2026-02-11；修回：2026-04-19；录用：2026-04-20）
［60］GAN Y，ZHOU L，WANG R，et al. Curcumol reduces aer⁃ （本文编辑：唐 震）